CoChat

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Continuous glucose monitoring (CGM) has become a widely used tool in the ambulatory setting for monitoring glucose levels, as well as detecting uncontrolled hyperglycemia, hypoglycemia, and glycemic variability. The accuracy of some CGM systems has recently improved to the point of manufacture with factory calibration and Food and Drug Administration clearance for nonadjunctive use to dose insulin. In this commentary, we analyze the answers to six questions about what is needed to bring CGM into the hospital as a reliable, safe, and effective tool. The evidence to date indicates that CGM offers promise as an effective tool for monitoring hospitalized patients. During the current coronavirus disease 2019 crisis, we hope to provide guidance to healthcare professionals, who are seeking to reduce exposure to SARS-Cov-2, as well as preserve invaluable personal protective equipment. In this commentary, we address who, what, where, when, why, and how CGM can be adopted for inpatient use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1932296820932903

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The Ambulatory Glucose Profile Report (AGP) is a standardized, single page report used in the outpatient setting. 31 This report could be adapted for inpatient diabetes care with integration to electronic health records. Step-by-step instructions for interpreting the data: http://www.agpreport.org/agp/sites/default/files/CGM_Clinical_Guide_AGP.pdf. Source: http://www.agpreport.org/agp/about.
Figure 1. The Ambulatory Glucose Profile Report (AGP) is a standardized, single page report used in the outpatient setting. 31 This report could be adapted for inpatient diabetes care with integration to electronic health records. Step-by-step instructions for interpreting the data: http://www.agpreport.org/agp/sites/default/files/CGM_Clinical_Guide_AGP.pdf. Source: http://www.agpreport.org/agp/about.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 4

  1. Nacoti M, 2020, NEJM Catal, 1
  2. Dexcom. Press release. https://www.dexcom.com/hospitalfacts. Accessed April 12, 2020.
  3. Abbott. Press release. https://abbott.mediaroom.com/2020-04-08-Abbotts-FreeStyle-R-Libre-14-Day-System-Now-Available-in-U-S-for-Hospitalized-Patients-with-Diabetes-During-COVID-19-Pandemic. Accessed April 12, 2020.
  4. Wake DJ, Eur J Endocrinol

Cited by

See all 155

Metadata

Authors
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J.
Affiliations
  • Emory University (US)
  • Northwestern University (US)
  • San Mateo Medical Center (US)
  • University of Maryland, Baltimore (US)
  • Albert Einstein College of Medicine (US)
Corresponding author
Pasquel, Francisco J.
Venue
Journal of Diabetes Science and Technology
Published
2020-06-14
Volume
14
Issue
4
Pages
822-832
ISSN
1932-2968 (ISSN-L)
OpenAlex
W3034681791
Cited by
155
References
31
Citations by year
2026: 15 · 2025: 24 · 2024: 26 · 2023: 23 · 2022: 20 · 2021: 36 · 2020: 11
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK-111024)
  • national institutes of health (1K23DK123384-01, P30DK11102, K23DK115896, P30DK111022, 1K23DK113241, 1K23GM128221-01A1)
  • VA MERIT (#1I01CX001825)
  • NIH/NATS (UL1 TR002378, 1P30DK111024-01)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, hospital implementation, remote glucose monitoring, COVID-19 pandemic, personal protective equipment, hospitalized patients, glycemic variability, hypoglycemia, hyperglycemia, insulin dose, inpatient diabetes management
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, Blood Glucose, Calibration, Communicable Disease Control, Diabetes Mellitus, Hospitalization, Hospitals, Humans, Hyperglycemia, Inpatients, Insulin Infusion Systems, Pneumonia, Viral, United States, United States Food and Drug Administration, Blood Glucose Self-Monitoring, Coronavirus Infections, Monitoring, Ambulatory, Diabetes Complications, Electronic Health Records, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. https://app.cochat.ai/papers/10.1177/1932296820932903
The paper
Galindo, R. J., Aleppo, G., Klonoff, D. C., Spanakis, E. K., Agarwal, S., Vellanki, P., Olson, D. E., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2020). Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820932903

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.